Dynavax Technologies Corporation (DVAX)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Income Tumbles by -96.55 % at DVAX amid the second quarter of 2023
Breaking down first quarter of 2023 effort, the company*s saw very demanding period
Revenues receded by -5.423 %, at the company during the fiscal period closing Dec 31 2022
Interesting performance by the company in the most recent fiscal period
results have grown rapidly the Dynavax Technologies Corp over the April to June 30 2022 interval
Breathtaking quarter by the company over the fiscal period ending March 31 2022
A remarkable performance by the company over the October to December 31 2021 three months